Add to ORKGThe Rare Cancer Network (RCN) was formed in the early 1990’s to create a global network that could pool knowledge and resources in the studies of rare malignancies whose infrequency prevented both their study with prospective clinical trials. To date, the RCN has initiated 74 studies resulting in 46 peer reviewed publications. The First International Symposium of the Rare Cancer Network took place in Nice in March of 2014. Status updates and proposals for new studies were heard for fifteen topics. Ongoing studies continue for cardiac sarcomas, thyroid can-cers, glomus tumors, and adult medulloblas
Introduction: Rare cancers together account for about 22% of new cancer diagnoses each year, which i...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
The Rare Cancer Network (RCN) was formed in the early 1990’s to create a global network that could p...
The Rare Cancer Network (RCN) was formed in the early 1990's to create a global network that could p...
The Rare Cancer Network (RCN) was formed in the early 1990's to create a global network that could p...
Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, ...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Approximately, twenty years ago, the Rare Cancer Network ...
To date, the <em>Rare Cancer Network</em> (RCN) has initiated more than 90 studies and 54 peer-revie...
To date, the Rare Cancer Network (RCN) has initiated more than 90 studies and 54 peer-reviewed publi...
The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not...
The present and future opportunities of the RareCancer Network: an international consortium for adva...
Rare cancers represent approximately one fourth of all cancers. Despite being a heterogeneous group ...
The management of rare cancers is controversial. The role of adjuvant therapies, such as chemotherap...
The widespread incidence and effects of cancer have led to a growing development in cancer preventio...
Introduction: Rare cancers together account for about 22% of new cancer diagnoses each year, which i...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
The Rare Cancer Network (RCN) was formed in the early 1990’s to create a global network that could p...
The Rare Cancer Network (RCN) was formed in the early 1990's to create a global network that could p...
The Rare Cancer Network (RCN) was formed in the early 1990's to create a global network that could p...
Approximately, twenty years ago, the Rare Cancer Network (RCN) was formed in Lausanne, Switzerland, ...
İstanbul Bilim Üniversitesi, Tıp Fakültesi.Approximately, twenty years ago, the Rare Cancer Network ...
To date, the <em>Rare Cancer Network</em> (RCN) has initiated more than 90 studies and 54 peer-revie...
To date, the Rare Cancer Network (RCN) has initiated more than 90 studies and 54 peer-reviewed publi...
The Rare Cancer Network (RCN), founded in 1993, performs research involving rare tumors that are not...
The present and future opportunities of the RareCancer Network: an international consortium for adva...
Rare cancers represent approximately one fourth of all cancers. Despite being a heterogeneous group ...
The management of rare cancers is controversial. The role of adjuvant therapies, such as chemotherap...
The widespread incidence and effects of cancer have led to a growing development in cancer preventio...
Introduction: Rare cancers together account for about 22% of new cancer diagnoses each year, which i...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...
Because of the low incidence, and limited opportunities for large patient volume experiences, there ...